2008
DOI: 10.1002/jso.21087
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal Expression of p16INK4a, Cyclin D1, Cyclin‐Dependent Kinase 4 and Retinoblastoma Protein in Gastric Carcinomas

Abstract: The Rb pathway is disrupted in the vast majority of gastric carcinomas. This study also identified specific immunohistochemical marker profiles for prognosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
4
4

Year Published

2010
2010
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(41 citation statements)
references
References 33 publications
1
32
4
4
Order By: Relevance
“…We did not identify a statistical correlation between the presence of lymph node involvement and the immunohistochemical expression of p16 ink4a . This is a conflicting result compared with previous reports (30,31). Although the expression of p16 ink4a is altered in gastric tumors, this alteration is considered to be secondary to p53 mutations (5).…”
Section: Kip1contrasting
confidence: 62%
“…We did not identify a statistical correlation between the presence of lymph node involvement and the immunohistochemical expression of p16 ink4a . This is a conflicting result compared with previous reports (30,31). Although the expression of p16 ink4a is altered in gastric tumors, this alteration is considered to be secondary to p53 mutations (5).…”
Section: Kip1contrasting
confidence: 62%
“…Inactivation of P16 leads to excessive proliferation of cells. Kishimoto et al (2008) found that there are at least more than 2 abnormal expression of oncogene in the development of gastric cancer. Nearly 40%-50% cases were occurred in the absence of expression of P16/Rb and overexpress of CyclinD1/CDK4.…”
Section: Discussionmentioning
confidence: 99%
“…This was also supported by the observation that TRIM24 knockdown decreased the expression levels of the Wnt/β-catenin target genes, β-catenin, cyclinD1 and c-Myc. CyclinD1 is overexpressed in several types of cancer and serves as a regulator of cell cycle progression through the G1/S checkpoint (32)(33)(34). c-Myc is a nuclear phosphoprotein, which regulates the cell cycle and apoptosis (35).…”
Section: A B C D E Fmentioning
confidence: 99%